Healthy Living Europe: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living Europe.

Press releases published on June 16, 2026

Jun. 16, 2026

Confluent Health Launches The Pain Perspective, Revealing a New National Portrait of Chronic Pain in America

Indeterminate GlobeNewswire

Jun. 16, 2026

Distalmotion Supports ASCs in Expanding GYN Service Lines with US FDA 510(k) Clearance for Additional Gynecology Indications

Indeterminate GlobeNewswire

Jun. 16, 2026

Creative Medical Technology Holdings, Inc. Advances Project PHOENIX into Nationwide AI Driven Virtual Data Collection Phase for U.S. Veterans Exposed to Burn Pits and Toxic Hazards

Indeterminate GlobeNewswire

Jun. 16, 2026

NeOnc Technologies Secures UAE IND Approval for NEO212 Following Successful Phase 1 Completion, Advancing Toward Global Phase 2 Development

Indeterminate GlobeNewswire

Jun. 16, 2026

WORK Medical Announces 1-for-100 Reverse Stock Split Effective June 18, 2026

Indeterminate GlobeNewswire

Jun. 16, 2026

Oncolytics Biotech® Secures New U.S. Patent Protecting Commercial Manufacturing of Pelareorep into 2044

Indeterminate GlobeNewswire

Jun. 16, 2026

NEW VIELIGHT-SUPPORTED STUDY FINDS IMPROVEMENTS IN MEMORY AND BRAIN FUNCTION IN A PILOT TRIAL FOR MILD COGNITIVE IMPAIRMENT

Indeterminate GlobeNewswire

Jun. 16, 2026

Sharecare selected by Georgia Department of Community Health to advance rural health transformation through GREAT Health Program

Indeterminate GlobeNewswire

Jun. 16, 2026

Propanc Biopharma’s CEO Tours European CDMO & Plans for GMP Production of PRP for Phase 1b, FIH Study

Indeterminate GlobeNewswire

Jun. 16, 2026

Acronis e Eyetech, partner MSP, fanno parte dell'iniziativa #TeamUp per sensibilizzare i bambini di Malta alla sicurezza informatica

Indeterminate GlobeNewswire

Jun. 16, 2026

Entera Reports Robust Preclinical Data for EB612 (Oral LA-PTH(1-34)) for Hypoparathyroidism and EB618 (Oral GLP-1/Glucagon) for Obesity at ENDO 2026

Indeterminate GlobeNewswire

Jun. 16, 2026

AI-Driven Ion Exchange Materials Market Attracts $73M in Investment Funding as Water Treatment Digitization Accelerates

Indeterminate GlobeNewswire

Jun. 16, 2026

FibroBiologics Advances Patient Dosing for Phase 1/2 Clinical Trial of CYWC628 for the Treatment of Diabetic Foot Ulcers

Indeterminate GlobeNewswire

Jun. 16, 2026

Optimi Health Launches Standardized Microdose Psilocybin Products for Clinical Research

Indeterminate GlobeNewswire

Jun. 16, 2026

Microbot Medical® Enters Into an Agreement to Expand Access for America’s Veteran and Military Patient Populations

Indeterminate GlobeNewswire

Jun. 16, 2026

Quoin Pharmaceuticals Announces Positive Clinical Update from Ongoing Pediatric Netherton Syndrome Compassionate Use Program

Indeterminate GlobeNewswire

Jun. 16, 2026

Intelligent Bio Solutions Initiates Clinical Study Supporting FDA Clearance and Planned U.S. Market Entry

Indeterminate GlobeNewswire

Jun. 16, 2026

NewGen Eliminates Convertible Note and Warrant Overhang with a Significant Investor, Enters Into Settlement Agreement Strengthening Capital Structure

Indeterminate GlobeNewswire

Jun. 16, 2026

CDT Equity Announces Debt Update and New Loan Facility

Indeterminate GlobeNewswire

Jun. 16, 2026

Outlook Therapeutics Announces FDA Acceptance of Resubmitted Biologics License Application for ONS-5010/LYTENAVA™ (bevacizumab-vikg) as a Treatment for Wet AMD

Indeterminate GlobeNewswire